Stonehaven specialists can help you carefully analyse the benefits and drawbacks of potential mergers and acquisitions. We explore financial projections, operating overlaps and cultural fit to give your company an edge in the global human pharma market. If it makes sense to move forward, we can structure the deal to the benefit of all stakeholders.
Our associates have extensive experience in assisting clients with mergers and acquisitions across various sectors, including Human Pharma, Animal Health, Medical devices and Nutrition. We work tirelessly to help you determine price, manage negotiations, minimize risk post-acquisition and figure out the tax structure of merger and acquisition agreements. Our custom Merger and Acquisition Package covers all stages of the process – from M&A advisory and financings to initiation, negotiation and finalization of transactions.
The virtuous cycle for M&A begins with Stonehven building a strong M&A capability that forms the foundation for the success of the model through five key steps:
Based on our analysis and years of experience with global Pharmaceutical and Animal Health players as well as smaller companies and start-ups —our mergers and acquisitions experts believe that the key to successful M&A is a repeatable model; one that lets companies reap substantial rewards.
Stonehaven’s Merger and Acquisition consultants help companies in the pharma and medical sectors build and execute on their own repeatable models for M&A. We apply our expertise to guide organizations and management teams where to grow through joint ventures and alliances or divestitures and separations in a global landscape.